Berkeley Capital Partners, LLC Abb Vie Inc. Transaction History

Berkeley Capital Partners, LLC

$347 Million
Q3 2024

A detailed history of Berkeley Capital Partners, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Berkeley Capital Partners, LLC holds 7,977 shares of ABBV stock, worth $1.44 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares

7,977

Previous 7,204 10.73%

Holding current value

$1.44 Million

Previous $1.24 Million 27.53%

% of portfolio

0.45%

Previous 0.37%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$163.84 - $199.33 $126,648 - $154,082	773 Added 10.73%	7,977 $1.58 Million
Q2 2024 Aug 14, 2024	SELL	$154.79 - $180.76 $2,786 - $3,253	-18 Reduced 0.25%	7,204 $1.24 Million
Q1 2024 May 14, 2024	SELL	$159.82 - $182.1 $30,845 - $35,145	-193 Reduced 2.6%	7,222 $1.32 Million
Q4 2023 Feb 09, 2024	SELL	$137.6 - $154.97 $18,713 - $21,075	-136 Reduced 1.8%	7,415 $1.15 Million
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $7,614 - $8,815	57 Added 0.76%	7,551 $1.13 Million
Q2 2023 Aug 03, 2023	BUY	$132.51 - $164.9 $3,975 - $4,947	30 Added 0.4%	7,494 $1.01 Million
Q1 2023 May 02, 2023	BUY	$144.61 - $166.54 $40,201 - $46,298	278 Added 3.87%	7,464 $1.19 Million
Q4 2022 Feb 10, 2023	SELL	$138.31 - $165.87 $27,108 - $32,510	-196 Reduced 2.66%	7,186 $1.16 Million
Q3 2022 Nov 04, 2022	BUY	$134.21 - $153.93 $3,221 - $3,694	24 Added 0.33%	7,382 $991,000
Q2 2022 Aug 04, 2022	BUY	$137.62 - $174.96 $3,440 - $4,374	25 Added 0.34%	7,358 $1.13 Million
Q1 2022 May 05, 2022	BUY	$131.98 - $163.75 $122,873 - $152,451	931 Added 14.54%	7,333 $1.19 Million
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $19,981 - $25,282	-186 Reduced 2.82%	6,402 $867,000
Q3 2021 Nov 04, 2021	SELL	$106.4 - $120.78 $10,852 - $12,319	-102 Reduced 1.52%	6,588 $711,000
Q2 2021 Aug 16, 2021	BUY	$105.21 - $117.21 $5,470 - $6,094	52 Added 0.78%	6,690 $754,000
Q1 2021 May 04, 2021	BUY	$102.3 - $112.62 $29,564 - $32,547	289 Added 4.55%	6,638 $718,000
Q4 2020 Jan 28, 2021	BUY	$80.49 - $108.67 $965 - $1,304	12 Added 0.19%	6,349 $680,000
Q3 2020 Nov 03, 2020	BUY	$85.91 - $100.83 $20,446 - $23,997	238 Added 3.9%	6,337 $555,000
Q2 2020 Jul 30, 2020	BUY	$73.37 - $98.18 $14,307 - $19,145	195 Added 3.3%	6,099 $599,000
Q1 2020 Apr 21, 2020	BUY	$64.5 - $97.79 $20,898 - $31,683	324 Added 5.81%	5,904 $450,000
Q4 2019 Jan 24, 2020	SELL	$72.13 - $90.25 $108,555 - $135,826	-1,505 Reduced 21.24%	5,580 $494,000
Q3 2019 Nov 01, 2019	SELL	$62.98 - $75.72 $68,963 - $82,913	-1,095 Reduced 13.39%	7,085 $536,000
Q2 2019 Aug 08, 2019	BUY	$65.7 - $83.98 $159,191 - $203,483	2,423 Added 42.09%	8,180 $595,000
Q1 2019 Apr 30, 2019	BUY	$77.14 - $90.79 $81,459 - $95,874	1,056 Added 22.46%	5,757 $464,000
Q4 2018 Jan 28, 2019	BUY	$77.85 - $96.01 $365,972 - $451,343	4,701 New	4,701 $433,000

Others Institutions Holding ABBV

# of Institutions

3,849

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $320B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Berkeley Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Berkeley Capital Partners, LLC with notifications on news.

Account

Berkeley Capital Partners, LLC Abb Vie Inc. Transaction History